Boston Scientific lifts annual profit forecast, sees smaller tariff impact
Boston Scientific
raised its
annual profit forecast
on Wednesday, banking on strong demand for its
heart devices
, and trimmed its expectation for tariff-related costs to half of the previously projected amount.
Shares of the company rose 4.8% in morning trading following the results.
"Based on the current schedule of expected tariffs, we now anticipate a full-year headwind of about $100 million, down from a $200 million estimate," CFO John Monson said during a call with analysts.
The company expects to offset the remaining
tariff impact
through strong sales performance, favorable product mix and spending control, Monson added.
A rise in surgical procedures has boosted sales for medical device makers such as Boston Scientific, helping counter broader concerns about healthcare spending.
Executives credited strong trial results and expanded product indications for fueling physician adoption of key cardiovascular devices such as
Watchman
and Farapulse, the firm's main growth drivers that saw steady quarterly demand.
The company said the proposed rules by the Centers for Medicare & Medicaid Services regarding certain cardiac procedures would further benefit its technologies.
Farapulse, which is approved in the U.S. for some patients with intermittent atrial fibrillation, competes with Johnson & Johnson's Varipulse and Medtronic's PulseSelect in the pulsed field ablation (PFA) market.
Rival Johnson & Johnson last week posted strong medtech sales, aided by its heart devices, Varipulse and Trupulse.
JP Morgan analyst Robbie Marcus said the profit forecast raise was larger than many had expected, especially given Boston Scientific is now moving past the initial U.S. rollout of Farapulse.
"That said, the outlook still appears conservative to us," Marcus added.
Boston Scientific now expects 2025 adjusted profit of $2.95 to $2.99 per share, up from its prior view of $2.87 to $2.94.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
Bryan Johnson net worth 2025: Inside the fortune of the anti-aging tech millionaire
Bryan Johnson discusses brain-computer technology, age reversal, and Bryan AI as part of his goal to outlive biology. If you've been anywhere near the world of tech, wellness, or longevity trends in the past year, chances are you've heard of Bryan Johnson. No, he's not a Hollywood actor or a pop star, but his name carries some serious buzz. Why? Because this former tech entrepreneur has made it his life's mission to reverse aging. And he's putting his money where his mitochondria are. So just how much is Bryan Johnson worth in 2025? And what exactly is he doing with his millions? Who is Bryan Johnson? Before he became the poster child for age reversal, Johnson made his fortune in fintech. In 2013, he sold his company Braintree, which had acquired the now-ubiquitous Venmo, to PayPal for a cool $800 million. That single deal gave him the kind of financial freedom most people only dream about. But instead of retiring to a beach in the Maldives, Johnson decided to go full cyborg and challenge human biology itself. Now in his mid-40s, Johnson isn't interested in slowing down. In fact, he's doing the opposite, he's trying to turn back the biological clock. What's Bryan Johnson's net worth in 2025? As of mid-2025, Bryan Johnson's net worth is estimated to be around $400 million to $500 million. That's down from the nearly $800 million peak he hit after the Braintree deal, but it's by no means a fall from grace. In fact, much of that decline is intentional—he's spending millions annually on his passion project: Project Blueprint. He's been pretty transparent about his finances and his radical wellness routine. Johnson has said he spends $2 million per year on his health, tracking everything from his liver enzymes to his erections (yes, really). With a team of 30+ doctors and specialists, he's essentially turned himself into a full-time lab experiment with one goal: stop aging. Johnson's Blueprint includes everything from daily MRIs, vegan meals weighed to the gram, and sleep monitoring, to bizarre experiments like plasma transfusions from his teenage son (a move that made headlines—and raised eyebrows). He's invested heavily in anti-aging research, building out a company called Kernel, which focuses on brain-machine interfaces and cognitive enhancement. He's also pouring money into startups and science-driven platforms that align with his 'future of humanity' vision. It's not just about the cash—though there's plenty of it. It's also about the cultural moment Bryan Johnson has tapped into. In an era where longevity science, biohacking, and performance tracking are trending hard, Johnson has become a lightning rod. Some call him a pioneer, others call him eccentric. Either way, he's getting results: his biological age (as measured by various markers) is said to be nearly 10 years younger than his actual age. Bryan Johnson isn't your typical millionaire. He's not buying islands or launching space rockets. He's investing in himself—literally—and trying to become the 'most optimized human' on Earth. While critics question whether all the data, testing, and green mush smoothies are worth it, Johnson seems undeterred.
Economic Times
3 days ago
- Economic Times
Bryan Johnson's Plan-B if anti-ageing company Blueprint fails might not be a high-tech idea
Synopsis Biotech entrepreneur Bryan Johnson, known for his anti-ageing initiative Blueprint, has revealed he's considering selling or shutting down the venture, citing it as a burden and saying he no longer finds it worthwhile. Despite clarifying that the company is financially stable, Johnson shared that it interferes with his personal philosophy and credibility. Shortly after the interview, he posted a viral photo of himself dressed as a pizza delivery man, joking about his backup plan if Blueprint doesn't work out—drawing praise online for his humour. Bryan Johnson's Backup Plan Has the Internet Talking Biotech entrepreneur Bryan Johnson, widely recognized for his relentless quest to reverse ageing, has hinted at walking away from his health-focused venture, Blueprint. Known for spending nearly $2 million annually on medical procedures, diagnostics, and extreme wellness routines, Johnson recently hinted that he might contemplating either selling the company or shutting it down 47-year-old shared a photo of himself on Instagram dressed as a pizza delivery person with the tongue-in-cheek caption, 'If Blueprint doesn't work out.' The image quickly went viral, prompting waves of online amusement. Social media users responded positively to the post, praising Johnson's ability to poke fun at himself. Some likened him to a video game character, while others joked about his moustache or simply appreciated the humour in his backup plan. View this post on Instagram A post shared by Bryan Johnson (@bryanjohnson_) Johnson's light-hearted post followed a candid interview with Wired, where he explained his growing disinterest in continuing with Blueprint. While the company brought him widespread visibility for promoting his 'Don't Die' philosophy, he acknowledged that operating the business had become stated that he had already begun speaking to potential buyers, and the thought of maintaining the venture no longer excited him. According to Johnson, running Blueprint has begun to interfere with how seriously his philosophy is taken, as people now associate him too strongly with the commercial side of his work.'I don't need the money, and it's a pain-in-the-a** company,' he told Wired, underlining his willingness to part ways with it despite its notoriety. Addressing rumours about financial trouble, Johnson clarified that Blueprint is not in distress. He said the company operates at a break-even point and has experienced both profitable and loss-making months. Despite the balanced financials, the stress of managing the venture appears to be a bigger factor in his decision. Blueprint, launched in 2021, attracted attention due to Johnson's radical longevity efforts, including intensive medical testing, highly structured diets, and strict exercise regimens.
Time of India
3 days ago
- Time of India
Bryan Johnson's Plan-B if anti-ageing company Blueprint fails might not be a high-tech idea
Biotech entrepreneur Bryan Johnson , widely recognized for his relentless quest to reverse ageing, has hinted at walking away from his health-focused venture, Blueprint. Known for spending nearly $2 million annually on medical procedures, diagnostics, and extreme wellness routines, Johnson recently hinted that he might contemplating either selling the company or shutting it down altogether. The 47-year-old shared a photo of himself on Instagram dressed as a pizza delivery person with the tongue-in-cheek caption, 'If Blueprint doesn't work out.' The image quickly went viral, prompting waves of online amusement. Social media users responded positively to the post, praising Johnson's ability to poke fun at himself. Some likened him to a video game character, while others joked about his moustache or simply appreciated the humour in his backup plan. Explore courses from Top Institutes in Please select course: Select a Course Category Data Science Management others Degree CXO Data Science Others healthcare Product Management Artificial Intelligence PGDM Technology Public Policy Leadership Finance Operations Management Project Management Data Analytics MBA Digital Marketing MCA Cybersecurity Skills you'll gain: Strategic Data-Analysis, including Data Mining & Preparation Predictive Modeling & Advanced Clustering Techniques Machine Learning Concepts & Regression Analysis Cutting-edge applications of AI, like NLP & Generative AI Strategic Data-Analysis, including Data Mining & Preparation Predictive Modeling & Advanced Clustering Techniques Machine Learning Concepts & Regression Analysis Cutting-edge applications of AI, like NLP & Generative AI Duration: 8 Months IIM Kozhikode Professional Certificate in Data Science and Artificial Intelligence Starts on Jun 26, 2024 Get Details Skills you'll gain: Strategic Data-Analysis, including Data Mining & Preparation Predictive Modeling & Advanced Clustering Techniques Machine Learning Concepts & Regression Analysis Cutting-edge applications of AI, like NLP & Generative AI Duration: 8 Months IIM Kozhikode Professional Certificate in Data Science and Artificial Intelligence Starts on Jun 26, 2024 Get Details View this post on Instagram A post shared by Bryan Johnson (@bryanjohnson_) 'Pain-in-the-A Company', Says Johnson Johnson's light-hearted post followed a candid interview with Wired, where he explained his growing disinterest in continuing with Blueprint. While the company brought him widespread visibility for promoting his 'Don't Die' philosophy, he acknowledged that operating the business had become burdensome. He stated that he had already begun speaking to potential buyers, and the thought of maintaining the venture no longer excited him. According to Johnson, running Blueprint has begun to interfere with how seriously his philosophy is taken, as people now associate him too strongly with the commercial side of his work. 'I don't need the money, and it's a pain-in-the-a** company,' he told Wired, underlining his willingness to part ways with it despite its notoriety. Clarifies Financial Status Amid Exit Talk Addressing rumours about financial trouble, Johnson clarified that Blueprint is not in distress. He said the company operates at a break-even point and has experienced both profitable and loss-making months. Despite the balanced financials, the stress of managing the venture appears to be a bigger factor in his decision. Blueprint, launched in 2021, attracted attention due to Johnson's radical longevity efforts, including intensive medical testing, highly structured diets, and strict exercise regimens.
